Genetic variation in the dectin-1/CARD9 recognition pathway and susceptibility to candidemia

Journal of Infectious Diseases

Volumn 204, Issue 7, 2011, Pages 1138-1145

  Rosentul, Diana C ^a   Plantinga, Theo S ^a   Oosting, Marije ^a   Scott, William K ^b   Velez Edwards, Digna R ^c   Smith, P Brian ^d   Alexander, Barbara D ^d   Yang, John C ^e   Laird, Gregory M ^d   Joosten, Leo A B ^a   Van Der Meer, Jos W M ^a   Perfect, John R ^d   Kullberg, Bart Jan ^a   Netea, Mihai G ^a   Johnson, Melissa D ^d,f  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e DEPARTMENT OF MEDICINE   (United States)

^f Campbell University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CASPASE RECRUITMENT DOMAIN PROTEIN 9; DECTIN 1; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANDIDA ALBICANS; CANDIDEMIA; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INCIDENCE; INFECTION SENSITIVITY; MUCOSAL IMMUNITY; NETHERLANDS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES;

AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; CANDIDEMIA; CARD SIGNALING ADAPTOR PROTEINS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERFERON-GAMMA; INTERLEUKINS; LEUKOCYTES, MONONUCLEAR; MEMBRANE PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80052423297     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir458     Document Type: Article

References (23)

1. Perlroth J., Choi B., Spellberg B. Nosocomial fungal infections: Epidemiology, diagnosis, and treatment. Med Mycol 2007; 45:321-346 (Pubitemid 46839802)
2. Spellberg B. Novel insights into disseminated candidiasis: Pathogenesis research and clinical experience converge. PLoS Pathog 2008; 4:e38.
3. Netea M.G., Brown G.D., Kullberg B.J., Gow N.A. An integrated model of the recognition of Candida albicans by the innate immune system. Nat Rev Microbiol 2008; 6:67-78. (Pubitemid 350286221)
4. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001; 1:135-145 (Pubitemid 33741967)
5. Brown G.D., Gordon S. Immune recognition. A new receptor for beta-glucans. Nature 2001; 413:36-37 (Pubitemid 32843478)
6. Brown G.D., Herre J., Williams D.L., Willment J.A., Marshall A.S., Gordon S. Dectin-1 mediates the biological effects of beta-glucans. J Exp Med 2003; 197:1119-1124 (Pubitemid 36570067)
7. Brown G.D. Dectin-1: A signalling non-TLR pattern-recognition receptor. Nat Rev Immunol 2006; 6:33-43. (Pubitemid 43279751)
8. Gantner B.N., Simmons R.M., Canavera S.J., Akira S., Underhill D.M. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J Exp Med 2003; 197:1107-1117 (Pubitemid 36570066)
9. Gross O., Gewies A., Finger K., et al. Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature 2006; 442:651-656 (Pubitemid 44215314)
10. Reid D.M., Gow N.A., Brown G.D. Pattern recognition: Recent insights from dectin-1. Curr Opin Immunol 2009; 21:30-37
11. Ferwerda B., Ferwerda G., Plantinga T.S., et al. Human dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med 2009; 361:1760-1767
12. Glocker E.O., Hennigs A., Nabavi M., et al. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med 2009; 361:1727-1735
13. Frazer K.A., Ballinger D.G., Cox D.R., et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007; 449:851-861
14. Venselaar H., Te Beek T.A., Kuipers R.K., Hekkelman M.L., Vriend G. Protein structure analysis of mutations causing inheritable diseases. An e-Science approach with life scientist friendly interfaces. BMC Bioinformatics 2010; 11:548.
15. Ramensky V., Bork P., Sunyaev S. Human non-synonymous SNPs: Server and survey. Nucleic Acids Res 2002; 30:3894-3900 (Pubitemid 35012462)
16. Bochud P.Y., Chien J.W., Marr K.A., et al. Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. N Engl J Med 2008; 359:1766-1777
17. Carvalho A., Pasqualotto A.C., Pitzurra L., Romani L., Denning D.W., Rodrigues F. Polymorphisms in toll-like receptor genes and susceptibility to pulmonary aspergillosis. J Infect Dis 2008; 197:618-621 (Pubitemid 351321541)
18. Van der Graaf C.A., Netea M.G., Morre S.A., et al. Toll-like receptor 4 Asp299Gly/Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection. Eur Cytokine Netw 2006; 17:29-34.
19. Woehrle T., Du W., Goetz A., et al. Pathogen specific cytokine release reveals an effect of TLR2 Arg753Gln during Candida sepsis in humans. Cytokine 2008; 41:322-329
20. Plantinga T.S., Van der Velden W.J., Ferwerda B., et al. Early. stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients. Clin Infect Dis 2009; 49:724-732
21. Gow N.A., Netea M.G., Munro C.A., et al. Immune recognition of Candida albicans beta-glucan by dectin-1. J Infect Dis 2007; 196:1565-1571 (Pubitemid 351411994)
22. Netea M.G., Gow N.A., Munro C.A., et al. Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. J Clin Invest 2006; 116:1642-1650
23. Vriend G. WHAT IF: A molecular modeling and drug design program. J Mol Graph 1990; 8:52-629.